CN Patent

CN118986905B — 一种甲磺酸阿帕替尼片及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2025-04-29 · 1y expired

What this patent protects

本发明属于药物制剂技术领域，本发明提供了一种甲磺酸阿帕替尼片剂及其制备方法。本发明制得的甲磺酸阿帕替尼片，通过粉末状羟基化大豆磷脂和葡甲胺的加入有效的改善了片剂的溶出度。片剂制备工艺简单，片剂产品质量稳定。

USPTO Abstract

本发明属于药物制剂技术领域，本发明提供了一种甲磺酸阿帕替尼片剂及其制备方法。本发明制得的甲磺酸阿帕替尼片，通过粉末状羟基化大豆磷脂和葡甲胺的加入有效的改善了片剂的溶出度。片剂制备工艺简单，片剂产品质量稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN118986905B
Jurisdiction
CN
Classification
—
Expires
2025-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.